Cargando…
The glycosylation landscape of pancreatic cancer
Pancreatic adenocarcinoma is a lethal disease with a 5-year survival rate of <5%, the lowest of all types of cancer. The diagnosis of pancreatic cancer relies on imaging and tissue biopsy, and the only curative therapy is complete surgical resection. Pancreatic cancer has the propensity to metast...
Autor principal: | Munkley, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388511/ https://www.ncbi.nlm.nih.gov/pubmed/30854032 http://dx.doi.org/10.3892/ol.2019.9885 |
Ejemplares similares
-
Hallmarks of glycosylation in cancer
por: Munkley, Jennifer, et al.
Publicado: (2016) -
Altered glycosylation in pancreatic cancer and beyond
por: Lumibao, Jan C., et al.
Publicado: (2022) -
The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016) -
Aberrant Sialylation in Cancer: Therapeutic Opportunities
por: Munkley, Jennifer
Publicado: (2022) -
Glycans as Biomarkers in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2019)